Scarica l'app Stockscreener
136.99
5.84%
-8.50
Dopo l'orario di chiusura:
137.00
0.010
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Repligen Corp Borsa (RGEN) Ultime notizie
A Look at Repligen Corp (RGEN) After 5.9% Decline -- GF Value $1 - GuruFocus
Why Repligen (RGEN) Stock Is Trading Lower Today - Yahoo Finance
Form 4 Repligen Corporation For: 17 July By Investing.com - Investing.com Nigeria
Insider Sell: Jason Garland Sells Shares of Repligen Corp (RGEN) - GuruFocus
Repligen CFO Jason K Garland sells $79,500 in stock - Investing.com
Repligen CFO Jason K Garland sells $79,500 in stock By Investing.com - Investing.com Canada
Repligen (NASDAQ: RGEN) CFO trades 530 shares in 10b5-1 plan sale - Stock Titan
Repligen (RGEN) Stock Looks Fairly Valued On Cash Flow But Fully Priced On Sales - Yahoo Finance
Form 144 REPLIGEN CORP For: 16 July - Investing.com UK
Form 144 REPLIGEN CORP For: 16 July By Investing.com - Investing.com South Africa
Issuer RGEN (NASDAQ: RGEN) plans 530-share sale by Form 144 filer - Stock Titan
RGEN5964422 Bond Profile — Key Metrics - TradingView
Repligen to report Q2 2026 financial results on July 28 - scanx.trade
Repligen Schedules 8 a.m. ET Webcast for July 28 Results - Stock Titan
Repligen Corporation to Report Second Quarter 2026 Financial Results on July 28, 2026 - Quiver Quantitative
ETFs Investing in Repligen Corporation Stocks - TradingView
Is It Too Late to Buy Repligen Corp (RGEN) After 4.7% Rally? GF Value Says Undervalued - GuruFocus
Repligen stock trades steadily as bioprocessing demand shapes investor focus - ad-hoc-news.de
3 Reasons RGEN is Risky and 1 Stock to Buy Instead - Yahoo Finance
Should Repligen's (RGEN) Russell Growth Index Removal Require Action From Current Investors? - simplywall.st
Repligen Corp business overview and stock context - Ad-hoc-news.de
REPLIGEN CORP : BENCHMARK RAISES TO BUY FROM HOLD - Moomoo
RGEN Upgraded by Benchmark -- Price Target Announced at $185 - GuruFocus
Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160 - Moomoo
RGEN Maintained by Evercore ISI Group -- Price Target Raised to $160 - GuruFocus
Is Repligen Corporation (RGEN) A Good Stock To Buy Now? - Insider Monkey
Here’s Why Repligen Corp. (RGEN) Fell 28% in Q1 - Insider Monkey
A Look at Repligen Corp (RGEN) After 6.8% Decline -- GF Value $1 - GuruFocus
Repligen Corp (RGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Biolife Is Said to Have Drawn Takeover Interest From Repligen - Bloomberg.com
Repligen (RGEN) CFO completes 733-share Rule 10b5-1 stock sale - Stock Titan
A Look at Repligen Corp (RGEN) After 4.9% Gain -- GF Value $175. - GuruFocus
Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer - The Motley Fool
Form 144 REPLIGEN CORP For: 25 June By Investing.com - Investing.com Australia
[144] REPLIGEN CORP SEC Filing - Stock Titan
Repligen jumps as investors revisit strong Q1 results and bioprocessing recovery outlook - Quiver Quantitative
Repligen Corporation (RGEN) Dropped Following the Earnings Release - Insider Monkey
Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tel - GuruFocus
Repligen StockLong-term strategy and bioprocessing niche - AD HOC NEWS
Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools - Insider Monkey
RGEN Technical Analysis & Stock Price Forecast - Intellectia AI
Repligen Corp (RGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Repligen Corp (RGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Repligen Corp (RGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Repligen Corp (RGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Repligen Corp (RGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Repligen Corp (RGEN) Institutional Confidence - TradingKey
Repligen Corp (RGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Repligen Corp (RGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MFS Mid Cap Growth Series's Repligen Corp(RGEN) Holding History - GuruFocus
RBC Capital Resumes Repligen Corp (RGEN) Stock Coverage. Here’s Its View - Insider Monkey
0.63%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):